Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
62 Cards in this Set
- Front
- Back
drugs are available in conventional dosage forms and have no bioequivalence problems
|
AA
|
|
drugs that have actual or potential bioequivalence problems, but the problems have been resolved by adequate scientific evidence
|
AB
|
|
bioequivalent sol’ns and powders for aerosolization (nebulizer)
|
AN
|
|
bioequivalent injectable oil soln’s
|
AO
|
|
bioequivalent injectable aqueous sol’ns and some IV non-aqueous sol’ns
|
AP
|
|
bioequivalent topical drugs
|
AT
|
|
drugs in extended release dosage forms with bioequivalence issues
|
BC
|
|
active ingredients in dosage forms with documented bioequivalence problems
|
BD
|
|
delayed-release oral dosage forms with potential bioequivalence problems
|
BE
|
|
products in aerosol-nebulizer drug delivery systems unless proven bioequivalent
|
BN
|
|
active ingredients in dosage forms with potential bioequivalence problems
|
BP
|
|
suppositories or enemas that deliver drugs for systemic absorption unless proven bioequivalent
|
BR
|
|
products with drug standard deficiencies
|
BS
|
|
topical drug products with bioequivalence issues
|
BT
|
|
products with insufficient data to determine therapeutic equivalence
|
BX
|
|
drugs that cannot be determined for therapeutic equivalence until certain questions are
resolved |
B*
|
|
Lysergic acid diethylamide
|
Schedule I
|
|
Mescaline
|
Schedule I
|
|
Psilocybin
|
Schedule I
|
|
Methaqualone
|
Schedule I
|
|
Codeine
|
Schedule II
|
|
Cocaine
|
Schedule II
|
|
Meperidine
|
Schedule II
|
|
Dihydrocodeine
|
Schedule II
|
|
Diphenoxylate
|
Schedule II
|
|
Phenmatrizine
|
Schedule II
|
|
Amibarbital
Pentobarbital Secobarbital |
Schedule II
|
|
Phencyclidine
|
Schedule II
|
|
Mixed preparation of
Amibarbital Pentobarbital Secobarbital |
Schedule III
|
|
Phenobarbital
|
Schedule IV
|
|
Lysergic acid or methyprylone suppository
|
Schedule III
|
|
Aspirin or Acetaminophen and codeine
|
Schedule III
|
|
Nalorphine
|
Schedule III
|
|
Benzphetamine
|
Schedule III
|
|
Chlorphentermine
|
Schedule III
|
|
Clortermine
|
Schedule III
|
|
Phendimetrazine
|
Schedule III
|
|
Anabolic steroids
|
Schedule III
|
|
Dronabinol
|
Schedule III
|
|
Ketamine
|
Schedule III
|
|
Approved GHB
|
Schedule III
|
|
Paregoric
|
Schedule III
|
|
Dextropropyphene
|
Schedule IV
|
|
May not contain more than:
1.8 g codeine or dihydrocodeine/100 mL, or not >90 mg/dosage unit |
Schedule III
|
|
May not contain more than:
300 mg dihydrocodeinone and ethylmorphine/100 mL, or not >15 mg/dosage unit |
Schedule III
|
|
May not contain more than:
500 mg of opium/100 mL or /100 g, or not >25 mg/dosage unit |
Schedule III
|
|
May not contain more than:
50 mg of morphine/100 mL or 100 g |
Schedule III
|
|
May not contain more than:
1 mg difenoxin |
Schedule IV
|
|
More than:
25 micrograms of atropine sulfate |
Schedule IV
|
|
Chloral hydrate
|
Schedule IV
|
|
Chlordiazepoxide
|
Schedule IV
|
|
Diethylpropion
|
Schedule IV
|
|
Phentermine
|
Schedule IV
|
|
Pentazocine
|
Schedule IV
|
|
Cannot contain more than:
200 mg codeine/100 mL or /100 g |
Schedule V
|
|
Cannot contain more than:
100 mg dihydrocodeine, ethylmorphine, or opium /100 mL or /100 g |
Schedule V
|
|
Cannot contain more than:
2.5 mg diphenoxylate, and not <25 μg atropine sulfate/dosage unit |
Schedule V
|
|
Cannot contain more than:
0.5 mg difenoxin, not <25 μg atropine sulfate/dosage unit |
Schedule V
|
|
Form 106
|
Theft of loss of controlled substance
|
|
Form 222
|
Ordering or returning schedule I or II controlled substances to a supplier
|
|
Form 224 (a and b also)
|
Initial registration form for pharmacies, if considered a dispenser
Form 224a: completed by pharmacies for renewal Form 224b: completed by chain pharmacies for renewal, aka “Retail Pharmacy Chain Affidavit” or blanket renewal |
|
Form 225
|
Initial registration form for manufacturers, distributors and narcotic treatment program
|